Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

106.72 +0.07 (+0.07%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,428,199
Open 106.36
Bid (Size) 106.30 (3)
Ask (Size) 106.72 (2)
Prev. Close 106.65
Today's Range 105.04 - 107.74
52wk Range 66.89 - 134.76
Shares Outstanding 96,748,901
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Is Abbott Laboratories a Good Dividend Stock to Buy Now?
At least four Wall Street banks recently raised their price targets for the healthcare giant. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
 
Via Benzinga

Performance

YTD
-6.98%
-6.98%
1 Month
-5.78%
-5.78%
3 Month
-11.64%
-11.64%
6 Month
+27.31%
+27.31%
1 Year
-0.84%
-0.84%

More News

Read More
Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Procter & Gamble's Prices, China's Population, and More
Via The Motley Fool
1 Top Growth Stock That Could Beat the Market In 2023 and Beyond
Via The Motley Fool
2 No-Brainer Growth Stocks to Buy Right Now
Via The Motley Fool
Insulet Has Potential To Gain More Than Analysts Are Forecasting
Via MarketBeat
The Top 7 “Millionaire-Maker” Long-Term Stocks for 2023
Via InvestorPlace
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
Via Investor's Business Daily
Analyst Expectations for DexCom's Future
Via Benzinga
10 Analysts Have This to Say About DexCom
Via Benzinga
2 Best Stocks to Buy in January and Hold Forever
Via The Motley Fool
Want $1 Million in Retirement? Invest $300,000 in These 3 Stocks and Wait a Decade
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook
From DexCom, Inc.
Via Business Wire
Dexcom Appoints Teri Lawver as Chief Commercial Officer
From DexCom, Inc.
Via Business Wire
Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference
From DexCom, Inc.
Via Business Wire
Have $2,000 to Invest? 2 Top Stocks That Could Go Parabolic
Via The Motley Fool
2 Growth Stocks to Invest $1,500 in Before the End of 2022
Via The Motley Fool
The Best Stocks to Invest $5,000 in Right Now
Via The Motley Fool
1 Passive Income Stock to Buy Today, and 1 to Avoid for Now
Via The Motley Fool
2 Breakout Growth Stocks to Buy for the Long Haul
Via The Motley Fool
Can FDA Approval Bolster DexCom, Inc.?
Via MarketBeat
Exposures Product Safety
Kaival Brands ($KAVL) and KMS gear up for anticipated revenue growth by hiring former Swisher International VP of Sales
Via AB Newswire
Topics Economy
Exposures Interest Rates
Stock Market Rally Falls On Recession Fears; Tesla Plunges On China News: Weekly Review
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.